HER2DX confirms the ability of the test to predict long-term survival and response to anti-HER2 therapy in BC

Treatment decision guided by CTC count may improve long-term outcomes for mBC

The future of precision oncology

The concept of pan-tumour therapeutics

Access to Oncology Medicines Coalition - The Medicines Patent Pool

Intraoperative ultrasound is accurate for guiding breast conservative surgery in non-palpable ductal breast carcinoma

Challenges and opportunities of integrative oncology as an effective tool to enhance cancer prevention and treatment in LMICs.

Monitoring and evaluation as a tool for quality improvement in cancer screening

Cloud software for helping build quality assurance in radiotherapy

Is Latin America ready to overcome the challenges of implementing Precision Medicine?

UICC / WHO Policy dialogue: Maintaining cancer care in times of conflict and environmental emergencies

ARCHERY trial: Testing AI for radiotherapy